Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD 371 in Healthy Subjects
Clinical trial NCT05544214 · COMPLETED
Trial details
- NCT number
- NCT05544214
- Sponsor
- Chong Kun Dang Pharmaceutical
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-21
- Primary completion
- 2022-11-14
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.